A novel 1,25-dihydroxyvitamin D - Activin A pathway in human alveolar macrophages is dysfunctional in patients with pulmonary alveolar proteinosis (PAP)

Autoimmunity

Volumn 42, Issue 1, 2009, Pages 56-62

  Barna, Barbara P ^a   Malur, Anagha ^a   Dalrymple, Heidi ^a   Karnekar, Reema ^a   Culver, Daniel A ^b   Abraham, Susamma ^b   Singh, Ravinder J ^c   Brescia, Donald ^a   Kavuru, Mani S ^a   Thomassen, Mary Jane ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Activin A; Alveolar macrophage; Cathelicidin; Vitamin D

Indexed keywords

ACTIVIN A; CALCITRIOL; CATHELICIDIN; LIPOPOLYSACCHARIDE; THIOREDOXIN; VITAMIN D RECEPTOR;

ADULT; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENE TARGETING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ALVEOLUS MACROPHAGE; LUNG ALVEOLUS PROTEINOSIS; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MALE; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN DEFICIENCY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; VITAMIN D DEFICIENCY;

ACTIVINS; ADULT; ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CELLS, CULTURED; DIHYDROXYCHOLECALCIFEROLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LYMPHOCYTE ACTIVATION; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, INBRED C57BL; PULMONARY ALVEOLAR PROTEINOSIS;

EID: 58149485204     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930802316277     Document Type: Article

References (38)

1. Vale, W., Rivier, J. Vaughan, J. et al. (1986) Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature, 321:6072, pp. 776-779.
2. Ling, N., Ying, SY Ueno, N. et al. (1986) Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature, 321:6072, pp. 779-782.
3. Yamato, K., Koseki, T. Ohguchi, M. et al. (1997) Activin A induction of cell-cycle arrest involves modulation of cyclin D2 and p21CIP1/WAF1 in plasmacytic cells. Mol Endocrinol, 11:8, pp. 1044-1052.
4. Ogawa, K., Funaba, M. Chen, Y. et al. (2006) Activin A functions as a Th2 cytokine in the promotion of the alternative activation of macrophages. J Immunol, 177:10, pp. 6787-6794.
5. Shao, L., Frigon Jr., NL Sehy, DW et al. (1992) Regulation of production of activin A in human marrow stromal cells and monocytes. Exp Hematol, 20:10, pp. 1235-1242.
6. Yu, J., Shao, LE and Frigon Jr, NL (1996) Induced expression of the new cytokine, activin A, in human monocytes: Inhibition by glucocorticoids and retinoic acid. Immunology, 88:3, pp. 368-374.
7. Matsuse, T., Fukuchi, Y. Eto, Y. et al. (1995) Expression of immunoreactive and bioactive activin A protein in adult murine lung after bleomycin treatment. Am J Respir Cell Mol Biol, 13:1, pp. 17-24.
8. Cho, SH, Yao, Z. Wang, SW et al. (2003) Regulation of activin A expression in mast cells and asthma: Its effect on the proliferation of human airway smooth muscle cells. J Immunol, 170:8, pp. 4045-4052.
9. Kitamura, T., Tanaka, N. Watanabe, J. et al. (1999) Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med, 190, pp. 875-880.
10. Seymour, JF and Presneill, JJ (2002) Pulmonary alveolar proteinosis (progress in the first 44 years). Am J Respir Crit Care Med, 166, pp. 215-235.
11. Dranoff, G., Crawford, AD Sadelain, M. et al. (1994) Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science, 264, pp. 713-716.
12. Stanley, E., Lieschke, GJ Grail, D. et al. (1994) Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA, 91, pp. 5592-5596.
13. Reed, JA, Ikegami, M. Cianciolo, ER et al. (1999) Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice. Am J Physiol, 276, pp. L556-L563.
14. Kavuru, MS and Popovich, M. (2002) Therapeutic whole lung lavage: A stop-gap therapy for alveolar proteinosis. Chest, 122:4, pp. 1123-1124.
15. Bonfield, TL, Barna, BP John, N. et al. (2006) Suppression of activin A in autoimmune lung disease associated with anti-GM-CSF. J Autoimmun, 26:1, pp. 37-41.
16. Wang, TT, Tavera-Mendoza, LE Laperriere, D. et al. (2005) Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol, 19:11, pp. 2685-2695.
17. Van, EE and Mathieu, C. (2005) Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts. J Steroid Biochem Mol Biol, 97:1, pp. 93-101.
18. Kavuru, MS, Sullivan, EJ Piccin, R. et al. (2000) Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis. Am J Respir Crit Care Med, 161, pp. 1143-1148.
19. Mazzone, P., Thomassen, MJ and Kavuru, M. (2001) Our new understanding of pulmonary alveolar proteinosis: What an internist needs to know. Clev Clin J Med, 68, pp. 977-992.
20. Mazzone, PJ, Thomassen, MJ and Kavuru, MS (2002) Pulmonary alveolar proteinosis: Recent advances. Semin Respir Critical Care Med, 23:2, pp. 115-126.
21. Thomassen, MJ, Yi, T. Raychaudhuri, B. et al. (2000) Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect. Clin Immunol, 95, pp. 85-92.
22. Bonfield, TL, Raychaudhuri, B. Malur, A. et al. (2003) PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor. Am J Physiol Lung Cell Mol Physiol, 285:5, pp. L1132-L1136.
23. Bonfield, TL, Farver, CF Barna, BP et al. (2003) Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis. Am J Respir Cell Mol Biol, 29:6, pp. 677-682.
24. Singh, RJ, Taylor, RL Reddy, GS et al. (2006) C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab, 91:8, pp. 3055-3061.
25. Holick, MF (2007) Vitamin D deficiency. New Engl J Med, 357:3, pp. 266-281.
26. Wang, TT, Nestel, FP Bourdeau, V. et al. (2004) Cutting edge: 1,25-Dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol, 173:5, pp. 2909-2912.
27. Liu, PT, Stenger, S. Li, H. et al. (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science, 311:5768, pp. 1770-1773.
28. Liu, PT, Stenger, S. Tang, DH et al. (2007) Cutting edge: Vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol, 179:4, pp. 2060-2063.
29. Boonstra, A., Barrat, FJ Crain, C. et al. (2001) 1alpha,25-Dihydroxyvitamin D3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol, 167:9, pp. 4974-4980.
30. Chen, S., Sims, GP Chen, XX et al. (2007) Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol, 179:3, pp. 1634-1647.
31. Penna, G. and Adorini, L. (2000) 1 alpha,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol, 164:5, pp. 2405-2411.
32. Herdick, M. and Carlberg, C. (2000) Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators. J Mol Biol, 304:5, pp. 793-801.
33. Tagami, T., Lutz, WH Kumar, R. et al. (1998) The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators. Biochem Biophys Res Commun, 253:2, pp. 358-363.
34. Adams, JS, Chen, H. Chun, R. et al. (2007) Substrate and enzyme trafficking as a means of regulating 1,25-dihydroxyvitamin D synthesis and action: The human innate immune response. J Bone Miner Res, 22, pp. V20-V24.
35. Lu, X., Farmer, P. Rubin, J. et al. (2004) Integration of the NFkappaB p65 subunit into the vitamin D receptor transcriptional complex: Identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription. J Cell Biochem, 92:4, pp. 833-848.
36. Ogawa, K., Funaba, M. Mathews, LS et al. (2000) Activin A stimulates type IV collagenase (matrix metalloproteinase-2) production in mouse peritoneal macrophages. J Immunol, 165:6, pp. 2997-3003.
37. Thomassen, MJ, Barna, BP Malur, A. et al. (2007) ABCG1 is deficient in alveolar macrophages of GM-CSF knock-out mice and patients with pulmonary alveolar proteinsosis. J Lipid Res, 48, pp. 2762-2768.
38. Mestas, J. and Hughes, CC (2004) Of mice and not men: Differences between mouse and human immunology. J Immunol, 172:5, pp. 2731-2738.